NCT04512833View on ClinicalTrials.gov

CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2026

Conditions
Hepatocellular Carcinoma
Interventions
RADIATION

Cyberknife stereotactic body radiation therapy

A total dose of 45-54 Gy in 5-10 fractions was given according to the location of lesions for small HCC patients with decompensated cirrhosis.

Trial Locations (1)

100039

RECRUITING

Beijing 302 hospital, Beijing

All Listed Sponsors
lead

Beijing 302 Hospital

OTHER